Skip to main content
. 2023 Nov 14;15(11):2623. doi: 10.3390/pharmaceutics15112623

Table 4.

Overall insights into regulatory and ethical challenges for BDS.

Categories Insights
Regulatory Challenges
  • Biological variability and complexity

  • Achieving consistent reproducibility

  • Potential unprecedented interactions with biological entities

Regulatory Frameworks
  • Adaptive oversight mechanisms

  • Interdisciplinary dialogues

  • Harmonized global standards

Ethical Challenges
  • Sourcing material from sentient entities (humans/animals)

  • Informed consent and potential exploitation

  • Equitable accessibility in diverse settings

Ethical Frameworks
  • Broadened boundaries of informed consent

  • Stakeholder participation

  • Pursuit of transparency